Not applicableStudy completedNCT04741152What this trial is testingBlinded Resection in Case of the Pancreatic InsulinomaWho this might be right forInsulinoma; Pancreas Vishnevsky Center of Surgery 197
Not applicableLooking for participantsNCT06725693What this trial is testingGlucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related DiseaseWho this might be right forGLP1-R-related DiseaseTumorInsulinoma+1 more Tianjin Medical University 500
Testing effectiveness (Phase 2)Study completedNCT02806648What this trial is testingA Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)Who this might be right forPancreatic Neuroendocrine Cancer Grupo Espanol de Tumores Neuroendocrinos 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784What this trial is testingAbemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine TumorsWho this might be right forAdvanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more University of Washington 20
Not applicableUnknownNCT05554744What this trial is testingEUS-FNI for MEN1-related Pancreatic Neuroendocrine TumorsWho this might be right forMultiple Endocrine Neoplasia Type 1Pancreatic Neuroendocrine Tumor Guangxi Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT02031536What this trial is testingEverolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With SurgeryWho this might be right forGastrinomaGlucagonomaInsulinoma+4 more ECOG-ACRIN Cancer Research Group 2
Not applicableStudy completedNCT01603004What this trial is testingPotential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine TumorsWho this might be right forPancreatic Neuroendocrine Cancer Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT06505395What this trial is testingA Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)Who this might be right forGastrointestinal Neuroendocrine Pancreatic Tumor CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 90
Not applicableNo Longer AvailableNCT01980732What this trial is testing68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive TumorsWho this might be right forCarcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors Andrei Iagaru
Not applicableUnknownNCT03033186What this trial is testingEverolimus TDM to Predict Long Term ToxicityWho this might be right forBreast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Early research (Phase 1)Study completedNCT02355535What this trial is testingProcaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Who this might be right forSolid TumorPancreatic Neuroendocrine TumorNeuroendocrine Tumors Vanquish Oncology, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01024387What this trial is testingAMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor Dana-Farber Cancer Institute 60
Large-scale testing (Phase 3)Study completedNCT00842348What this trial is testingStudy of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine TumourWho this might be right forNon Functioning Entero-pancreatic Endocrine Tumour Ipsen 89
Not applicableUnknownNCT03741517What this trial is testingBiomarker Study of Pancreatic Neuroendocrine TumoursWho this might be right forPancreatic Neuroendocrine Tumor Uppsala University 40
Testing effectiveness (Phase 2)Study completedNCT02420691What this trial is testingRibociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginWho this might be right forAdvanced Digestive System Neuroendocrine NeoplasmDuodenal Neuroendocrine Tumor G1Functional Pancreatic Neuroendocrine Tumor+5 more M.D. Anderson Cancer Center 21
Not applicableUnknownNCT03084770What this trial is testingAsymptomatic Small Pancreatic Endocrine Neoplasms.Who this might be right forNon Functioning Pancreatic Endocrine Tumor IRCCS San Raffaele 1,000
Testing effectiveness (Phase 2)Study completedNCT00001191What this trial is testingThe Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric AcidWho this might be right forGastrinomaZollinger Ellison Syndrome National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableStudy completedNCT01528774What this trial is testingCulture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersWho this might be right forMelanoma Wolfram Samlowski 150